Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study) von Liem, Kin Seng, Fung, Scott, Wong, David K, Yim, Colina, Noureldin, Seham, Chen, Jiayun, Feld, Jordan J, Hansen, Bettina E, Janssen, Harry L A

Volltext

Editorial: identifying candidates for pegylated interferon add‐on to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B – authors' reply von Liem, Kin Seng, Janssen, Harry L. A.

Volltext

Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy von Majeed, Nehna Abdul, Alawad, Ahmad Samer, Liem, Kin Seng, Takyar, Varun, Alter, Harvey, Feld, Jordan J., Janssen, Harry L. A., Ghany, Marc G.

Volltext

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B von Liem, Kin Seng, van Campenhout, Margo J. H., Xie, Qing, Brouwer, Willem Pieter, Chi, Heng, Qi, Xun, Chen, Liang, Tabak, Fehmi, Hansen, Bettina E., Janssen, Harry L. A.

Volltext

Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS... von Farag, Mina S, van Campenhout, Margo J.H, Sonneveld, M. J, Fung, Scott, van Erpecum, Karel J, Wong, David K, Verhey, Elke, de Man, Robert, De Knegt, Robert J, Brouwer, Johannes T, Baak, Hubertus C, Feld, Jordan J, Liem, Kin Seng, Boonstra, André, Hansen, Bettina E, Janssen, Harry L.A

Volltext

Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B von Farag, Mina S., Campenhout, Margo J. H., Sonneveld, M. J., Fung, Scott, Erpecum, Karel J., Wong, David K., Verhey, Elke, Man, Robert, De Knegt, Robert J., Brouwer, Johannes T., Baak, Hubertus C., Feld, Jordan J., Liem, Kin Seng, Boonstra, André, Hansen, Bettina E., Janssen, Harry L. A.

Volltext

Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B von Liem, Kin Seng, Chi, Heng, Fung, Scott, Wong, David K., Yim, Colina, Noureldin, Seham, Chen, Jiayun, Man, Robert A., Sarowar, Arif, Feld, Jordan J., Hansen, Bettina E., Hou, Jinlin, Peng, Jie, Janssen, Harry L. A.

Volltext

The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B von Johnson Valiente, Alexandra, Liem, Kin Seng, Schwarz, Kathleen B, Rosenthal, Philip, Murray, Karen F, Mogul, Douglas, Teckman, Jeffery, Rodriguez-Baez, Norberto, Schwarzenberg, Sarah Jane, Feld, Jordan J, Wong, David K, Lewis-Ximenez, Lia L, Lauer, Georg, Hansen, Bettina E, Ling, Simon C, Janssen, Harry L A, Gehring, Adam J

Volltext

Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS... von Farag, Mina S, van Campenhout, Margo J H, Sonneveld, M J, Fung, Scott, van Erpecum, Karel J, Wong, David K, Verhey, Elke, de Man, Robert, De Knegt, Robert J, Brouwer, Johannes T, Baak, Hubertus C, Feld, Jordan J, Liem, Kin Seng, Boonstra, André, Hansen, Bettina E, Janssen, Harry L A

Volltext

Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B von Liem, Kin Seng, Yim, Colina, Ying, Thomas D., Zanjir, Wayel R., Fung, Scott, Wong, David K., Shah, Hemant, Feld, Jordan J., Hansen, Bettina E., Janssen, Harry L. A.

Volltext

Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients von Liem, Kin Seng, Wong, David K., Fung, Scott, Zahirieh, Alireza, Yim, Colina, Zanjir, Wayel R., Feld, Jordan J., Hansen, Bettina E., Janssen, Harry L. A.

Volltext